Literature DB >> 12018966

Reversible valproate-induced choreiform movements.

Dilek Ince Gunal1, Meliha Guleryuz, Canan Aykut Bingol.   

Abstract

Valproate is an anticonvulsive drug whose mechanism of action is based on GABAergic systems. One of the infrequent adverse effects of valproate is choreiform movements. In our study, we report a patient having head trauma history with partial and secondary generalized seizures taking 1500 mg/day valproate. During the second month of the therapy, generalized chorea was observed. Since other aetiologic causes of chorea were excluded, acutely occurring chorea in the patient was thought to be related with valproate usage because of persistence of choreiform movements for days without any fluctuation. Valproate was stopped slowly and lamotrigine was added at a dose of 400 mg/day. Within a two-month period after cessation of the valproate, choreiform movements had disappeared. We thought that the history of head trauma and another antiepileptic drug usage were the risk factors for the occurrence of valproate-induced choreiform movements. Copyright 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12018966     DOI: 10.1053/seiz.2001.0576

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  4 in total

1.  Valproate-Induced Generalized Choreoathetosis.

Authors:  Alfonso Giordano; Marianna Amboni; Alessandro Tessitore
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

2.  A Complex Hyperkinesia Induced by Valproate.

Authors:  Elisa Bruno; Paul Holmes; Michalis Koutroumanidis
Journal:  Mov Disord Clin Pract       Date:  2016-01-29

3.  A case of lamotrigine-induced excessive involuntary eye blinking.

Authors:  Dong-Gun Kim; Seung-Hun Oh; Ok Joon Kim
Journal:  J Clin Neurol       Date:  2007-06-20       Impact factor: 3.077

Review 4.  The treatment of tremor.

Authors:  Susanne A Schneider; Günther Deuschl
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.